Funding for this research was provided by:
Vertex Pharmaceuticals (NA)
Text and Data Mining valid from 2020-02-01
First Online: 14 February 2020
: M.D.F. has no competing interests. S.J.T. is on scientific advisory boards for Triplet Therapeutics and LoQus therapeutics and has laboratory funding from Vertex pharmaceuticals.